Record-Breaking Impact of Gavi-Supported Vaccines in 2024
In 2024, the efforts of Gavi-supported vaccination programs achieved an unprecedented milestone by saving over 1.7 million lives. This figure marks a significant increase from the previous year, with an additional 400,000 lives saved compared to 2023. The progress made during this year highlights the critical role that immunization plays in addressing some of the world’s most pressing health challenges.
Gavi’s initiatives have not only contributed to public health but also generated substantial economic benefits. In 2024 alone, these programs created nearly US$ 20 billion in economic value for participating countries. This impact stems from healthier populations, reduced healthcare costs, and more productive communities. Since its establishment in 2000, Gavi has contributed to a total of US$ 280 billion in economic returns, demonstrating the long-term benefits of investing in vaccines.
Economic Benefits and Country Responsibility
The economic advantages of immunization extend beyond immediate health outcomes. By fostering healthier populations, Gavi-supported countries have seen improved productivity and reduced strain on healthcare systems. This trend has encouraged many nations to take greater responsibility for their own immunization programs. In 2024, countries paid a record amount of US$ 255 million towards the cost of their vaccines, reflecting a growing commitment to self-sufficiency in public health.
José Manuel Barroso, Chair of the Gavi Board, emphasized the importance of vaccines as one of the most cost-effective interventions in development. He noted that these efforts are not just about protecting lives but also about supporting economic growth and community resilience.
Malaria Vaccination and Conflict Zones
One of the most notable achievements in 2024 was the rapid rollout of the world’s first malaria vaccine. This initiative marked a historic moment in global health, as it began to protect millions of children across 23 African countries. These nations represent over 70% of the world’s malaria burden. Beyond malaria, Gavi reported increased coverage across all supported vaccines, even in some of the most challenging environments.
Eight out of twelve countries classified as experiencing fragility and conflict saw improvements in basic immunization coverage. Countries like Mali, Syria, and Haiti experienced major gains. However, conflict-affected regions such as Sudan and Yemen faced significant declines, highlighting the ongoing challenges in these areas.
Dr. Sania Nishtar, CEO of Gavi, expressed her commitment to ensuring that every individual, regardless of their location, has access to life-saving vaccines. She acknowledged the complexity of achieving this goal but praised the dedication of governments, healthcare workers, and communities worldwide.
Global Health Security and Future Goals
Since 2000, immunization efforts have significantly reshaped global health and security. Over 1.2 billion unique children have been immunized against various deadly diseases, surpassing Alliance goals ahead of schedule. Additionally, more than 2.1 billion vaccinations have been delivered through preventive campaigns, helping to protect communities from outbreaks.
Efforts to contain emerging threats have led to a reduction of nearly 60% in potential cases and deaths. Between 2000 and 2024, these combined efforts have prevented at least 20.6 million deaths. Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlighted the importance of sustained investment and collaboration in maintaining immunization as a cornerstone of global health action.
Leaping into the Future
The achievements of Gavi reflect the strength of its partnerships with both public and private sector entities. More importantly, they highlight the leadership of countries that prioritize the health and well-being of their populations. As Gavi moves forward, it is focused on expanding its country-led approach through the Gavi Leap reform program. This initiative aims to make immunization programs more responsive to the unique needs of each country, region, and community.
By driving efficiency and improving delivery at the last mile, Gavi continues to ensure that more children are protected against more diseases than ever before. The organization remains committed to its mission of making vaccines accessible to all, regardless of their circumstances.
